TMEM11

gene
On this page

Also known as PMIPM1

Summary

TMEM11 (transmembrane protein 11, HGNC:16823) is a protein-coding gene on chromosome 17p11.2, encoding Transmembrane protein 11, mitochondrial (P17152). Plays a role in mitochondrial morphogenesis.

Involved in mitochondrion organization. Located in mitochondrial inner membrane.

Source: NCBI Gene 8834 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 20 total
  • MANE Select transcript: NM_003876

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16823
Approved symbolTMEM11
Nametransmembrane protein 11
Location17p11.2
Locus typegene with protein product
StatusApproved
AliasesPMI, PM1
Ensembl geneENSG00000178307
Ensembl biotypeprotein_coding
OMIM618817
Entrez8834

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding_CDS_not_defined, 3 protein_coding

ENST00000317635, ENST00000577419, ENST00000583264, ENST00000583929, ENST00000584432, ENST00000584732, ENST00000873639, ENST00000918692

RefSeq mRNA: 1 — MANE Select: NM_003876 NM_003876

CCDS: CCDS11216

Canonical transcript exons

ENST00000317635 — 2 exons

ExonStartEnd
ENSE000013465242121409121214161
ENSE000027122202119795421198840

Expression profiles

Bgee: expression breadth ubiquitous, 278 present calls, max score 96.95.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 35.4389 / max 143.4590, expressed in 1820 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
16492333.92541820
1649240.7590517
1649260.6776382
1649250.077027

Top tissues by expression

287 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
hindlimb stylopod muscleUBERON:000425296.95gold quality
gastrocnemiusUBERON:000138896.84gold quality
muscle of legUBERON:000138396.64gold quality
muscle organUBERON:000163095.36gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451193.58gold quality
mucosa of transverse colonUBERON:000499193.12gold quality
apex of heartUBERON:000209892.76gold quality
skeletal muscle tissueUBERON:000113492.60gold quality
triceps brachiiUBERON:000150992.28gold quality
lower esophagus mucosaUBERON:003583492.12gold quality
biceps brachiiUBERON:000150792.11gold quality
skin of abdomenUBERON:000141691.90gold quality
skin of legUBERON:000151191.79gold quality
heart left ventricleUBERON:000208491.78gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450291.74gold quality
quadriceps femorisUBERON:000137791.62gold quality
vastus lateralisUBERON:000137991.62gold quality
cardiac ventricleUBERON:000208291.47gold quality
monocyteCL:000057691.13gold quality
right atrium auricular regionUBERON:000663191.06gold quality
omental fat padUBERON:001041490.91gold quality
peritoneumUBERON:000235890.88gold quality
olfactory segment of nasal mucosaUBERON:000538690.88gold quality
adipose tissue of abdominal regionUBERON:000780890.82gold quality
mononuclear cellCL:000084290.79gold quality
esophagus mucosaUBERON:000246990.71gold quality
leukocyteCL:000073890.70gold quality
zone of skinUBERON:000001490.41gold quality
transverse colonUBERON:000115790.34gold quality
esophagusUBERON:000104390.14gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes10.30
E-MTAB-7303no232.49

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): ZBTB17

miRNA regulators (miRDB)

28 targeting TMEM11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1193100.0065.93529
HSA-MIR-477599.9875.006394
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-590-3P99.9674.346478
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-6885-3P99.7570.363187
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-5571-5P99.4966.991764
HSA-MIR-122B-5P99.4670.811457
HSA-MIR-442799.3470.331854
HSA-MIR-580-5P99.2870.941776
HSA-MIR-324-3P99.2666.311034
HSA-MIR-548AS-3P99.1269.122294
HSA-MIR-3160-3P99.0764.78955
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-76098.8166.651392
HSA-MIR-6769B-5P98.7364.911092
HSA-MIR-4680-3P98.6468.602093
HSA-MIR-6818-3P98.5668.231307
HSA-MIR-6769A-5P97.9964.16851
HSA-MIR-55897.5067.16977
HSA-MIR-5187-3P97.2867.101037
HSA-MIR-5579-5P96.3268.54730
HSA-MIR-541-3P96.0766.111271
HSA-MIR-654-5P96.0766.181280
HSA-MIR-6781-5P94.6159.49155
HSA-MIR-6826-5P93.8067.42514

Literature-anchored findings (GeneRIF, showing 2)

  • study demonstrates that the Drosophila PMI gene and its human orthologue TMEM11 encode mitochondrial inner-membrane proteins that regulate mitochondrial morphogenesis (PMID:21274005)
  • The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3/BNIP3L-mediated mitophagy. (PMID:36795401)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotmem11ENSDARG00000070866
mus_musculusTmem11ENSMUSG00000043284
rattus_norvegicusTmem11ENSRNOG00000005377
drosophila_melanogasterPmiFBGN0044419

Protein

Protein identifiers

Transmembrane protein 11, mitochondrialP17152 (reviewed: P17152)

Alternative names: Protein PM1, Protein PMI

All UniProt accessions (1): P17152

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in mitochondrial morphogenesis.

Subunit / interactions. Associates with the mitochondrial contact site and cristae organizing system (MICOS) complex, composed of at least MICOS10/MIC10, CHCHD3/MIC19, CHCHD6/MIC25, APOOL/MIC27, IMMT/MIC60, APOO/MIC23/MIC26 and QIL1/MIC13. This complex was also known under the names MINOS or MitOS complex. The MICOS complex associates with mitochondrial outer membrane proteins SAMM50, MTX1, MTX2 and DNAJC11, mitochondrial inner membrane protein TMEM11 and with HSPA9. Interacts with IMMT/MIC60.

Subcellular location. Mitochondrion inner membrane.

Similarity. Belongs to the TMEM11 family.

RefSeq proteins (1): NP_003867* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026120TMEM11Family

Pfam: PF14972

UniProt features (4 total): transmembrane region 2, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P17152-F179.140.28

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8949613Cristae formation

MSigDB gene sets: 146 (showing top): YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10, MORF_MSH3, MORF_BRCA1, MORF_ATRX, MORF_ESR1, MORF_PPP5C, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, MORF_FANCG, GOCC_MITOCHONDRIAL_ENVELOPE, HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN, MORF_RAP1A, GOBP_MEMBRANE_ORGANIZATION, FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN, MORF_MT4, MORF_PPP2R5B

GO Biological Process (2): mitochondrion organization (GO:0007005), inner mitochondrial membrane organization (GO:0007007)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Mitochondrial biogenesis1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
organelle organization1
mitochondrial membrane organization1
binding1
cytoplasm1
intracellular membrane-bounded organelle1
organelle inner membrane1
mitochondrial membrane1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

1202 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TMEM11RRAGAQ7L523764
TMEM11RRAGBQ5VZM2706
TMEM11HRASP01112544
TMEM11RRAGCQ9HB90497
TMEM11RRAGDQ9NQL2497
TMEM11APOOLQ6UXV4486
TMEM11CCR5P51681479
TMEM11SMIM20Q8N5G0479
TMEM11IMMTQ16891475
TMEM11ARL6IP4Q66PJ3474
TMEM11DNAJC11Q9NVH1468
TMEM11MTX2O75431454
TMEM11NUB1Q9Y5A7447
TMEM11TMEM117Q9H0C3436
TMEM11KDELR1P24390431

IntAct

238 interactions, top by confidence:

ABTypeScore
BNIP3BNIP3Lpsi-mi:“MI:0914”(association)0.970
BNIP3TMEM11psi-mi:“MI:0915”(physical association)0.920
TMEM11BNIP3psi-mi:“MI:0915”(physical association)0.920
BNIP3LTMEM11psi-mi:“MI:0915”(physical association)0.840
TMEM11BNIP3Lpsi-mi:“MI:0915”(physical association)0.840
TMEM11KASH5psi-mi:“MI:0915”(physical association)0.700
KASH5TMEM11psi-mi:“MI:0915”(physical association)0.700
TMEM11FATE1psi-mi:“MI:0915”(physical association)0.670
TMEM11CREB3L1psi-mi:“MI:0915”(physical association)0.670
TNFSF14TMEM11psi-mi:“MI:0915”(physical association)0.670
BCAMLAMA5psi-mi:“MI:0914”(association)0.640
LRRC32SMPD2psi-mi:“MI:0914”(association)0.640
TMEM11MRM1psi-mi:“MI:0915”(physical association)0.560
TMEM11GJB4psi-mi:“MI:0915”(physical association)0.560
TMEM11RNASEH1psi-mi:“MI:0915”(physical association)0.560
TMEM11MUC1psi-mi:“MI:0915”(physical association)0.560
TMEM11YIPF6psi-mi:“MI:0915”(physical association)0.560

BioGRID (136): TMEM11 (Two-hybrid), TMEM11 (Two-hybrid), TMEM11 (Affinity Capture-RNA), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Two-hybrid), TMEM11 (Two-hybrid), TMEM11 (Affinity Capture-Western), FATE1 (Two-hybrid), CREB3L1 (Two-hybrid), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS), TMEM11 (Affinity Capture-MS)

ESM2 similar proteins: A2BD92, A4FV45, A5D7N3, A7S641, B0BN86, D3Z2R5, F1Q930, O76024, O95870, P17152, P97587, Q0IJ20, Q17QW2, Q1JPD2, Q1JPG0, Q2HJ63, Q3B8H3, Q4QQM5, Q5BK13, Q5BLE2, Q5RAS8, Q5RJQ8, Q5SWK7, Q5SYH2, Q5ZLD4, Q66H44, Q6DC66, Q6DF19, Q6GR21, Q6MG55, Q6NRI4, Q6NUQ4, Q6NWH5, Q6ZQE4, Q7L4E1, Q7SZC5, Q7ZW11, Q7ZWF4, Q7ZYA0, Q810L4

Diamond homologs: A2BD92, A5D7N3, B0BN86, P17152, Q3B8H3, Q5ZLD4, Q6NWH5, Q8BK08, Q8IQ56

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

20 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance19
Likely benign0
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

607 predictions. Top by Δscore:

VariantEffectΔscore
17:21198844:T:Cacceptor_gain1.0000
17:21198857:C:CTacceptor_gain1.0000
17:21198858:A:Tacceptor_gain1.0000
17:21198840:CCTTT:Cacceptor_gain0.9900
17:21198844:T:TCacceptor_gain0.9900
17:21198847:A:ACacceptor_gain0.9900
17:21214085:TCTCA:Tdonor_loss0.9900
17:21214086:CTCA:Cdonor_loss0.9900
17:21214087:TCA:Tdonor_loss0.9900
17:21214088:CA:Cdonor_loss0.9900
17:21214089:A:ATdonor_loss0.9900
17:21214090:CCTC:Cdonor_loss0.9900
17:21198836:TCACC:Tacceptor_gain0.9800
17:21198837:CACC:Cacceptor_gain0.9800
17:21198837:CACCC:Cacceptor_gain0.9800
17:21198839:CC:Cacceptor_gain0.9800
17:21198841:C:CCacceptor_gain0.9800
17:21198847:A:Cacceptor_gain0.9800
17:21208442:T:TAdonor_gain0.9800
17:21214090:CCT:Cdonor_gain0.9800
17:21214090:CCTCT:Cdonor_gain0.9800
17:21214089:A:ACdonor_gain0.9700
17:21214090:C:CCdonor_gain0.9700
17:21198843:T:TCacceptor_gain0.9600
17:21203736:C:CAdonor_gain0.9600
17:21198842:T:Cacceptor_gain0.9500
17:21208405:T:TAdonor_gain0.9500
17:21214134:T:TAdonor_gain0.9500
17:21214340:AGT:Adonor_gain0.9500
17:21198842:T:TCacceptor_gain0.9400

AlphaMissense

1224 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:21198427:A:GL159P1.000
17:21198427:A:TL159Q1.000
17:21198502:T:CY134C1.000
17:21198503:A:GY134H1.000
17:21198517:T:AD129V1.000
17:21198525:C:AW126C1.000
17:21198525:C:GW126C1.000
17:21198527:A:GW126R1.000
17:21198527:A:TW126R1.000
17:21198670:C:AG78V1.000
17:21198670:C:TG78D1.000
17:21198671:C:AG78C1.000
17:21198671:C:GG78R1.000
17:21198683:A:GW74R1.000
17:21198683:A:TW74R1.000
17:21198700:C:TG68D1.000
17:21198718:A:TI62N1.000
17:21198724:A:TI60N1.000
17:21198745:A:GL53P1.000
17:21198757:A:GL49P1.000
17:21198427:A:CL159R0.999
17:21198430:A:TV158E0.999
17:21198499:T:GQ135P0.999
17:21198502:T:GY134S0.999
17:21198503:A:CY134D0.999
17:21198510:G:CC131W0.999
17:21198511:C:TC131Y0.999
17:21198512:A:GC131R0.999
17:21198517:T:CD129G0.999
17:21198517:T:GD129A0.999

dbSNP variants (sampled 300 via entrez): RS1000091112 (17:21208912 G>A), RS1000155343 (17:21207658 C>A,G,T), RS1000229106 (17:21202992 G>A), RS1000239197 (17:21203226 A>T), RS1000351856 (17:21210927 T>A), RS1000588714 (17:21209247 G>A), RS1000594335 (17:21204704 T>C), RS1000863410 (17:21200631 C>G,T), RS1001148476 (17:21199259 G>A), RS1001172428 (17:21214948 C>A,T), RS1001581934 (17:21211326 C>T), RS1001638608 (17:21199076 C>A), RS1001701636 (17:21205968 G>A,C), RS1001862959 (17:21205422 G>C), RS1001929448 (17:21203704 A>G)

Disease associations

OMIM: gene MIM:618817 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005951_14Body mass index5.000000e-10
GCST009391_1409Metabolite levels7.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:00051325-HIAA measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, affects cotreatment, increases methylation2
Tobacco Smoke Pollutionincreases expression2
FR900359increases phosphorylation1
testosterone enanthateaffects expression1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, decreases expression, increases activity1
sodium arseniteaffects binding, increases reaction1
perfluorooctanoic acidincreases expression1
potassium chromate(VI)affects cotreatment, increases expression1
epigallocatechin gallateaffects cotreatment, increases expression1
di-n-butylphosphoric acidaffects expression1
cylindrospermopsinincreases expression1
corosolic aciddecreases expression1
bisphenol AFincreases expression1
Decitabineaffects methylation1
Sunitinibdecreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Atrazinedecreases expression1
Ivermectindecreases expression1
Smokedecreases expression1
Valproic Aciddecreases expression1
Vitamin Eincreases expression1
Cyclosporineincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.